Showing results (141-150 of 2,095) with videos related to
Sort By:
Pageof 210
Medicines (Basel, Switzerland)|June 20, 2019
Biological Potential and Medical Use of Secondary MetabolitesAna M L Seca, Diana C G A PintoCirculation Research|July 1, 1985
Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil functionM Bednar, B Smith, A Pinto, et al.Drug Discovery Today|May 28, 2019
Hot-melt extrusion in the pharmaceutical industry: toward filing a new drug applicationMarta F Simões, Rui M A Pinto, Sérgio SimõesThe New Microbiologica|August 11, 2001
Leptospira strains kept at the National Centre for Leptospirosis in Rome, ItalyL Ciceroni, A Pinto, S Ciarrocchi, et al.PDA Journal of Pharmaceutical Science and Technology|April 20, 2011
The bacterial diversity of pharmaceutical clean rooms analyzed by the Fatty Acid methyl ester techniqueFábio Luiz C Pacheco, Terezinha De Jesus A PintoClinical and Experimental Immunology|January 1, 1992
Evidence for prostaglandin-producing suppressor cells in drug-induced liver injury and implications in the diagnosis of drug sensitizationR M Victorino, V A Maria, L A PintoEuropean Heart Journal|August 1, 1992
Regression of structural vascular changes in hypertensives after captopril treatmentS Novo, M G Abrignani, A Pinto, et al.Journal of Medical Virology|December 1, 1991
Inhibition of lymphocyte proliferation induced in vitro by microbial antigens in HIV-infected subjectsV A Maria, L A Pinto, R M VictorinoPhysical Review. E|July 24, 2019
Inhibitory autapse mediates anticipated synchronization between coupled neuronsMarcel A Pinto, Osvaldo A Rosso, Fernanda S MatiasJournal of Medical Virology|October 1, 1995
T-helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individualsL A Pinto, M J Covas, R M VictorinoPageof 210